CSPC Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: HK1093012172
  • HKG: 1093
HKD
9.65
-0.06 (-0.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Wuxi Biologics (Cayman), Inc.
3SBio, Inc.
Alphamab Oncology
CSPC Pharmaceutical Group Ltd.
Sirnaomics Ltd.
Zai Lab Ltd.
AIM Vaccine Co., Ltd.
Ascentage Pharma Group International Co., Ltd.
Laekna, Inc.
Beijing Lüzhu Biotechnology Co., Ltd.
Genscript Biotech Corp.

Why is CSPC Pharmaceutical Group Ltd. ?

1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
  • The company is Net-Debt Free
2
With ROE of 5.72%, it has a Very Expensive valuation with a 2.17 Price to Book Value
  • Over the past year, while the stock has generated a return of -2.31%, its profits have risen by 25.8% ; the PEG ratio of the company is 1.7
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is CSPC Pharmaceutical Group Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
CSPC Pharmaceutical Group Ltd.
1.9%
0.79
48.43%
Hang Seng Hong Kong
-4.77%
-0.26
18.70%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.96%
EBIT Growth (5y)
19.40%
EBIT to Interest (avg)
29.07
Debt to EBITDA (avg)
2.63
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.34
Tax Ratio
19.81%
Dividend Payout Ratio
78.68%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
18.91%
ROE (avg)
14.36%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
38
Industry P/E
Price to Book Value
2.17
EV to EBIT
26.00
EV to EBITDA
21.52
EV to Capital Employed
2.57
EV to Sales
5.74
PEG Ratio
1.66
Dividend Yield
0.03%
ROCE (Latest)
9.89%
ROE (Latest)
5.72%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

24What is working for the Company
OPERATING CASH FLOW(Y)

Highest at HKD 22,670.56 MM

ROCE(HY)

Highest at 21.04%

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -6.49% (YoY

CASH AND EQV(HY)

Highest at HKD 21,434.56 MM

DEBT-EQUITY RATIO (HY)

Lowest at -47.56 %

DEBTORS TURNOVER RATIO(HY)

Highest at 3.52 times

DIVIDEND PER SHARE(HY)

Highest at HKD 3.52

NET SALES(Q)

Highest at HKD 21,197.35 MM

OPERATING PROFIT(Q)

Highest at HKD 9,127.77 MM

OPERATING PROFIT MARGIN(Q)

Highest at 43.06 %

PRE-TAX PROFIT(Q)

Highest at HKD 8,518.44 MM

NET PROFIT(Q)

Highest at HKD 6,888 MM

EPS(Q)

Highest at HKD 0.61

-1What is not working for the Company
DIVIDEND PAYOUT RATIO(Y)

Lowest at 29.54%

Here's what is working for CSPC Pharmaceutical Group Ltd.

Pre-Tax Profit
At HKD 8,518.44 MM has Grown at 168.93%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Net Profit
At HKD 6,888 MM has Grown at 167.43%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (HKD MM)

Operating Cash Flow
Highest at HKD 22,670.56 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Net Sales
Highest at HKD 21,197.35 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Net Sales
At HKD 21,197.35 MM has Grown at 48.67%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Operating Profit
Highest at HKD 9,127.77 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (HKD MM)

Operating Profit Margin
Highest at 43.06 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at HKD 8,518.44 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit
Highest at HKD 6,888 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS
Highest at HKD 0.61
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Cash and Eqv
Highest at HKD 21,434.56 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -47.56 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 3.52 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Dividend per share
Highest at HKD 3.52
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (HKD)

Raw Material Cost
Fallen by -6.49% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for CSPC Pharmaceutical Group Ltd.

Dividend Payout Ratio
Lowest at 29.54%
in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)

Footer loading
CSPC Pharmaceutical Group Ltd. (1093) Stock Recommendation | Score, Valuation, Technicals & Financial Trend